Population Pharmacokinetics of Indinavir in Patients Infected with Human Immunodeficiency Virus

Indinavir is currently used at a fixed dose of 800 mg either three times a day or twice a day in combination with 100 mg of ritonavir. Dosage individualization based on plasma concentration monitoring might, however, be indicated. This study aimed to assess the pharmacokinetic profile of indinavir i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Csajka, Chantal, Marzolini, Catia, Fattinger, Karin, Décosterd, Laurent A., Telenti, Amalio, Biollaz, Jérôme, Buclin, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2004
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC514769/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15328077/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.9.3226-3232.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados